プラズマ照射医薬品添加物を利用する DDS の新展開<SUP>1)</SUP>
スポンサーリンク
概要
- 論文の詳細を見る
As part of our continuing work on plasma chemistry and its application for the preparation of new pharmaceutically useful materials, we have examined preparations of multilayered particles applicable for DDS by use of plasma processing, and found that controlled-release tablet can be obtained by oxygen plasma irradiation (radio-frequency discharges operating at 13.56 MHz) on the outermost layer of the double-compressed tablet which were fabricated from theophylline tablet as a core material and a mixture of plasma-degradable polyoxymethylene (POM) and plasma-crosslinkable-polystyrene (PST) as a wall material. Dissolution test clearly indicated that the theophylline has been released from the tablet through the resulting micropore, whilst the release from untreated tablets was negligible. It was also found that dissolution profiles of theophylline can readily be controlled by the selection of a variety of factors for tablet fabrications as well as plasma operational conditions. One of the advantages of the present method over other methods is the avoidance of direct plasmaexposure to the drug.
論文 | ランダム
- Industrial Info. 吸収型α-グルコシダーゼ阻害薬ミグリトールの糖尿病治療薬としての位置付け
- 薬物療法 経口抗糖尿病薬 ビグアナイド薬 メトホルミンに関する最近の知見 (新時代の糖尿病学(3)病因・診断・治療研究の進歩) -- (糖尿病治療学の進歩)
- α-グルコシダーゼ阻害剤ミグリトールと吸着剤とのIn vitro薬物相互作用の検討
- 糖尿病食後過血糖改善剤投与の実際とその意義(最終回)症例から学ぶ α-グルコシダーゼ阻害薬の役割--ミグリトールは小腸上部で阻害活性を再現
- 新規α- グルコシダーゼ阻害薬ミグリトール(セイブル^【○!R】錠)の薬物動態学的および薬理学的特徴と臨床試験成績